Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs iShares MSCI Australia ETF (EWA) Price & Performance

AstraZeneca plcTrade
iShares MSCI Australia ETFTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs iShares MSCI Australia ETF — how do they compare? AstraZeneca plc trades at $158.11 (market cap $248.14B), while iShares MSCI Australia ETF trades at $30.23. The key difference: AstraZeneca plc pays a 2.01% dividend while iShares MSCI Australia ETF pays none, and iShares MSCI Australia ETF is trading nearer its 52-week high, AstraZeneca plc nearer its low. Which is the better fit depends on your goals.

AZNEWA
Market Cap
$248.14B
Sector
HealthBroad Market / Factor
52-Week High
$209.48$30.41
52-Week Low
$147.06$24.95
Enterprise Value
$275.41B
Dividend Yield
2.01%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About iShares MSCI Australia ETF

EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.

Read more on EWA